Genetic variations in the one-carbon metabolism pathway genes and susceptibility to hepatocellular carcinoma risk: a case–control study

Tumor Biology

Volumn 36, Issue 2, 2015, Pages 997-1002

  Zhang, Heng ^a   Liu, Chunhe ^a   Han, Yu Chen ^a   Ma, Zuohong ^b   Zhang, Haiyan ^a   Ma, Yinan ^a   Liu, Xiaofang ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b LIAONING CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Case control; Genetic; Hepatocellular carcinoma; One carbon metabolism; Polymorphism

Indexed keywords

CARBON; GART PROTEIN, HUMAN; LIGASE; PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANSFERASE; TRANSFERASE;

ADULT; ALLELE; ARTICLE; CANCER RISK; CARBON METABOLISM; CASE CONTROL STUDY; CBS GENE; CHINESE; CONTROLLED STUDY; FEMALE; FTHFD GENE; GART GENE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HEPATITIS B; HETEROZYGOTE; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MTHFR GENE; MTR GENE; MTRR GENE; PRIORITY JOURNAL; SHMT GENE; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; LIVER TUMOR; MIDDLE AGED; PATHOLOGY; RISK FACTOR;

ADULT; AGED; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CARBON-NITROGEN LIGASES; CARCINOMA, HEPATOCELLULAR; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; ONE-CARBON GROUP TRANSFERASES; PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANSFERASE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84925487164     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-2725-z     Document Type: Article

References (36)

1. Yuan JM, Ross RK, Stanczyk FZ, Govindarajan S, Gao YT, Henderson BE, et al. A cohort study of serum testosterone and hepatocellular carcinoma in Shanghai, China. Int J Cancer. 1995;63:491–3.
2. Zhang JY, Dai M, Wang X, Lu WQ, Li DS, Zhang MX, et al. A case-control study of hepatitis b and c virus infection as risk factors for hepatocellular carcinoma in Henan, China. Int J Epidemiol. 1998;27:574–8.
3. Yu MW, Yang YC, Yang SY, Chang HC, Liaw YF, Lin SM, et al. Androgen receptor exon 1 CAG repeat length and risk of hepatocellular carcinoma in women. Hepatology. 2002;36:156–63.
4. Su H, Zhao J, Xiong Y, Xu T, Zhou F, Yuan Y, et al. Large-scale analysis of the genetic and epigenetic alterations in hepatocellular carcinoma from Southeast China. Mutat Res. 2008;641:27–35.
5. Chen J, Ma L, Peng NF, Wang SJ, Li LQ. Relationship between GSTT1 gene polymorphism and hepatocellular carcinoma in patients from China. Asian Pac J Cancer Prev. 2012;13:4417–21.
6. Zheng J, Li C, Wu X, Yang Y, Hao M, Sheng S, et al. Astrocyte elevated gene-1 is a novel biomarker of epithelial-mesenchymal transition and progression of hepatocellular carcinoma in two China regions. Tumour Biol. 2014;35:2265–9.
7. Long XD, Zhao D, Wang C, Huang XY, Yao JG, Ma Y, et al. Genetic polymorphisms in DNA repair genes XRCC4 and XRCC5 and aflatoxin b1-related hepatocellular carcinoma. Epidemiology. 2013;24:671–81.
8. Song P. Standardizing management of hepatocellular carcinoma in China: devising evidence-based clinical practice guidelines. Biosci Trends. 2013;7:250–2.
9. Yang D, Hanna DL, Usher J, LoCoco J, Chaudhari P, Lenz HJ, Setiawan VW, El-Khoueiry A. Impact of sex on the survival of patients with hepatocellular carcinoma: a surveillance, epidemiology, and end results analysis. Cancer. 2014. doi:10.1002/cncr.28912.
10. El-Serag HB, Kanwal F. Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go?. Hepatology. 2014
11. Eggert T, McGlynn KA, Duffy A, Manns MP, Greten TF, Altekruse SF. Epidemiology of fibrolamellar hepatocellular carcinoma in the USA, 2000–10. Gut. 2013;62:1667–8.
12. Rustgi VK. Epidemiology of hepatocellular carcinoma. Gastroenterol Clin N Am. 1987;16:545–51.
13. Butler LM, Arning E, Wang R, Bottiglieri T, Govindarajan S, Gao YT, et al. Prediagnostic levels of serum one-carbon metabolites and risk of hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev. 2013;22:1884–93.
14. Wu MY, Kuo CS, Lin CY, Lu CL, Syu Huang RF. Lymphocytic mitochondrial DNA deletions, biochemical folate status and hepatocellular carcinoma susceptibility in a case-control study. Br J Nutr. 2009;102:715–21.
15. Rosen MP, Shen S, McCulloch CE, Rinaudo PF, Cedars MI, Dobson AT. Methylenetetrahydrofolate reductase (MTHFR) is associated with ovarian follicular activity. Fertil Steril. 2007;88:632–8.
16. Hustad S, Midttun O, Schneede J, Vollset SE, Grotmol T, Ueland PM. The methylenetetrahydrofolate reductase 677c → t polymorphism as a modulator of a B vitamin network with major effects on homocysteine metabolism. Am J Hum Genet. 2007;80:846–55.
17. Kasap M, Sazci A, Ergul E, Akpinar G. Molecular phylogenetic analysis of methylenetetrahydrofolate reductase family of proteins. Mol Phylogenet Evol. 2007;42:838–46.
18. Boccia S, Gianfagna F, Persiani R, La Greca A, Arzani D, Rausei S, et al. Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and susceptibility to gastric adenocarcinoma in an Italian population. Biomarkers. 2007;12:635–44.
19. Qian X, Lu Z, Tan M, Liu H, Lu D. A meta-analysis of association between C677T polymorphism in the methylenetetrahydrofolate reductase gene and hypertension. Eur J Hum Genet. 2007;15:1239–45.
20. Zhang W, Press OA, Haiman CA, Yang DY, Gordon MA, Fazzone W, et al. Association of methylenetetrahydrofolate reductase gene polymorphisms and sex-specific survival in patients with metastatic colon cancer. J Clin Oncol. 2007;25:3726–31.
21. Leclerc D, Rozen R. Endoplasmic reticulum stress increases the expression of methylenetetrahydrofolate reductase through the IRE1 transducer. J Biol Chem. 2008;283:3151–60.
22. Toniutto P, Fabris C, Falleti E, Cussigh A, Fontanini E, Bitetto D, et al. Methylenetetrahydrofolate reductase C677T polymorphism and liver fibrosis progression in patients with recurrent hepatitis C. Liver Int. 2008;28:257–63.
23. Qi X, Sun X, Xu J, Wang Z, Zhang J, Peng Z. Associations between methylenetetrahydrofolate reductase polymorphisms and hepatocellular carcinoma risk in Chinese population. Tumour Biol. 2014;35:1757–62.
24. Mu LN, Cao W, Zhang ZF, Cai L, Jiang QW, You NC, et al. Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298c polymorphisms and the risk of primary hepatocellular carcinoma (HCC) in a Chinese population. Cancer Causes Control. 2007;18:665–75.
25. Sun H, Han B, Zhai H, Cheng X, Ma K. Significant association between MTHFR C677T polymorphism and hepatocellular carcinoma risk: a meta-analysis. Tumour Biol. 2014;35:189–93.
26. Leclerc D, Campeau E, Goyette P, Adjalla CE, Christensen B, Ross M, et al. Human methionine synthase: cDNA cloning and identification of mutations in patients of the cbIG complementation group of folate/cobalamin disorders. Hum Mol Genet. 1996;5:1867–74.
27. Leclerc D, Wilson A, Dumas R, Gafuik C, Song D, Watkins D, et al. Cloning and mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria. Proc Natl Acad Sci U S A. 1998;95:3059–64.
28. Cheng C, Lingyan W, Yi H, Cheng Z, Huadan Y, Xuting X, et al. Association between TLR2, MTR, MTRR, XPC, TP73, TP53 genetic polymorphisms and gastric cancer: a meta-analysis. Clin Res Hepatol Gastroenterol. 2014;38:346–59.
29. Weiner AS, Boyarskikh UA, Voronina EN, Selezneva IA, Sinkina TV, Lazarev AF, et al. Polymorphisms in the folate-metabolizing genes MTR, MTRR, and CBS and breast cancer risk. Cancer Epidemiol. 2012;36:e95–100.
30. Jokic M, Brcic-Kostic K, Stefulj J, Catela Ivkovic T, Bozo L, Gamulin M, et al. Association of MTHFR, MTR, MTRR, RFC1, and DHFR gene polymorphisms with susceptibility to sporadic colon cancer. DNA Cell Biol. 2011;30:771–6.
31. Wettergren Y, Odin E, Carlsson G, Gustavsson B. MTHFR, MTR, and MTRR polymorphisms in relation to p16INK4A hypermethylation in mucosa of patients with colorectal cancer. Mol Med. 2010;16:425–32.
32. Hu J, Zhou GW, Wang N, Wang YJ. MTRR A66G polymorphism and breast cancer risk: a meta-analysis. Breast Cancer Res Treat. 2010;124:779–84.
33. Shrubsole MJ, Gao YT, Cai Q, Shu XO, Dai Q, Jin F, et al. MTR and MTRR polymorphisms, dietary intake, and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2006;15:586–8.
34. Welin M, Grossmann JG, Flodin S, Nyman T, Stenmark P, Tresaugues L, et al. Structural studies of tri-functional human GART. Nucleic Acids Res. 2010;38:7308–19.
35. Wynn SL, Fisher RA, Pagel C, Price M, Liu QY, Khan IM, et al. Organization and conservation of the GART/SON/DONSON locus in mouse and human genomes. Genomics. 2000;68:57–62.
36. Brodsky G, Barnes T, Bleskan J, Becker L, Cox M, Patterson D. The human GARS-AIRS-GART gene encodes two proteins which are differentially expressed during human brain development and temporally overexpressed in cerebellum of individuals with down syndrome. Hum Mol Genet. 1997;6:2043–50.